Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Bowel (colorectal) cancer, Colon cancer, Rectal cancer
Closed
Phase 2
This trial is looking at axitinib to treat bowel cancer that has spread to another part of the body (advanced bowel cancer).
Doctors can treat advanced bowel cancer with chemotherapy. But sometimes this doesn’t work and the cancer continues to grow. So they are always looking for new treatments.
Axitinib is a type of targeted cancer treatment called a tyrosine kinase inhibitor. The researchers think that axitinib may help people with advanced bowel cancer that has continued to grow despite having chemotherapy.
As a part of this trial, the researchers also want to look at measuring the blood flow to and from the liver using a new type of called a contrast enhanced ultrasound.
The aims of the trial are to
Find out how well axitinib works for people with advanced bowel cancer
Learn more about the side effects
Test the contrast enhanced ultrasound
Recruitment start: 5 September 2012
Recruitment end: 7 April 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Harpreet Wasan
Experimental Cancer Medicine Centre (ECMC)
Imperial College Healthcare NHS Trust
NIHR Clinical Research Network: Cancer
Pfizer
Last reviewed: 06 Apr 2016
CRUK internal database number: 9863
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
